{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T12:19:34Z","timestamp":1771762774709,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.ypmed.2007.08.006","type":"journal-article","created":{"date-parts":[[2007,8,24]],"date-time":"2007-08-24T12:05:32Z","timestamp":1187957132000},"page":"137-144","source":"Crossref","is-referenced-by-count":25,"title":["Aspirin use for the primary prevention of coronary heart disease: A population-based study in Switzerland"],"prefix":"10.1016","volume":"46","author":[{"given":"Nicolas","family":"Rodondi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Cornuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Marques-Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hayoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"P\u00e9coud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Paccaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Waeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Vollenweider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2007.08.006_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2007.08.006_bib2","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.ypmed.2007.08.006_bib3","first-page":"S72","article-title":"Aspirin therapy in diabetes","volume":"27","author":"Colwell","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ypmed.2007.08.006_bib4","first-page":"2008","article-title":"Prevention primaire et depistage chez l'adulte: quelles sont les priorites en 2002?","volume":"60","author":"Cornuz","year":"2002","journal-title":"Med. Hyg."},{"key":"10.1016\/j.ypmed.2007.08.006_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.286.2.180","article-title":"Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation","volume":"286","author":"D'Agostino","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2007.08.006_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00149831-200312001-00001","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts)","volume":"10","author":"De Backer","year":"2003","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.ypmed.2007.08.006_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1592\/phco.23.1.73.31923","article-title":"Improving aspirin prophylaxis in a primary care diabetic population","volume":"23","author":"Faragon","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ypmed.2007.08.006_bib8","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJM200206063462309","article-title":"Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease","volume":"346","author":"Gaspoz","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00415-005-0931-8","article-title":"Incidence of first-ever ischemic stroke in the Canton Basle-City, Switzerland: a population-based study 2002\/2003","volume":"253","author":"Gostynski","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.ypmed.2007.08.006_bib10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.CIR.100.9.988","article-title":"Primary prevention of coronary heart disease: integrating risk assessment with intervention","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ypmed.2007.08.006_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib12","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2007.08.006_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-136-2-200201150-00016","article-title":"Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"136","author":"Hayden","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/28.4.717","article-title":"Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study","volume":"28","author":"Hedman","year":"1999","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ypmed.2007.08.006_bib15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0195-668X(03)00081-2","article-title":"Framingham risk function overestimates risk of coronary heart disease in men and women from Germany-results from the MONICA Augsburg and the PROCAM cohorts","volume":"24","author":"Hense","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ypmed.2007.08.006_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amepre.2004.03.008","article-title":"Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System","volume":"27","author":"Kim","year":"2004","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib17","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJMcp012672","article-title":"Clinical practice. Aspirin for primary prevention of coronary events","volume":"346","author":"Lauer","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib18","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.291.21.2591","article-title":"Predictive value for the Chinese population of the Framingham CHD Risk Assessment Tool compared with the Chinese Multi-provincial Cohort Study","volume":"291","author":"Liu","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2007.08.006_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.amepre.2006.03.012","article-title":"Priorities among effective clinical preventive services: results of a systematic review and analysis","volume":"31","author":"Maciosek","year":"2006","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.thromres.2005.09.013","article-title":"Aspirin overprescription in primary cardiovascular prevention","volume":"118","author":"Manes","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ypmed.2007.08.006_bib21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/jech.57.8.634","article-title":"An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas","volume":"57","author":"Marrugat","year":"2003","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.ypmed.2007.08.006_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1525-1497.2000.03079.x","article-title":"Cardiovascular disease prevention practices by U.S. Physicians for patients with diabetes","volume":"15","author":"Meigs","year":"2000","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00228-005-0948-z","article-title":"Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?","volume":"61","author":"Monesi","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ypmed.2007.08.006_bib24","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"NCEP","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2007.08.006_bib25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel Guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ypmed.2007.08.006_bib26","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/archinte.164.22.2492","article-title":"Aspirin use among adults with diabetes: recent trends and emerging sex disparities","volume":"164","author":"Persell","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomised trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ypmed.2007.08.006_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group","volume":"321","author":"PHS","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.amepre.2007.01.010","article-title":"Aspirin use among adults aged 40 and older in the United States: results of a national survey","volume":"32","author":"Pignone","year":"2007","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib30","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bmj.313.7069.1368","article-title":"Variation in local policies and guidelines for cholesterol management: national survey","volume":"313","author":"Raine","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2007.08.006_bib31","first-page":"350","article-title":"Hospitalisations pour infarctus du myocarde dans les cantons de Vaud, Fribourg et Tessin: r\u00e9sultats de l'\u00e9tude MONICA pour la p\u00e9riode 1985\u20131988","volume":"50","author":"Rickenbach","year":"1992","journal-title":"M\u00e9d. Hyg."},{"key":"10.1016\/j.ypmed.2007.08.006_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib33","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.amjmed.2004.07.037","article-title":"Assessing the risk\/benefit profile before recommending aspirin for the primary prevention of cardiovascular events","volume":"117","author":"Rodondi","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib34","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.amjmed.2005.06.020","article-title":"Aspirin use for the primary prevention of coronary heart disease in older adults","volume":"118","author":"Rodondi","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/heart.85.3.265","article-title":"Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials","volume":"85","author":"Sanmuganathan","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.ypmed.2007.08.006_bib36","series-title":"Study Group Lipids and Atherosclerosis Recommendations for the Prevention of Atherosclerosis","author":"SGLA","year":"2005"},{"key":"10.1016\/j.ypmed.2007.08.006_bib37","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study","volume":"343","author":"SPAF","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2007.08.006_bib38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.CIR.101.10.1097","article-title":"Aspirin use is low among United States outpatients with coronary artery disease","volume":"101","author":"Stafford","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ypmed.2007.08.006_bib39","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1371\/journal.pmed.0020353","article-title":"Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease","volume":"2","author":"Stafford","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib40","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(99)04021-0","article-title":"Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease","volume":"353","author":"Tunstall-Pedoe","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2007.08.006_bib41","series-title":"Report of the U.S. Preventive Services Task Force","article-title":"Guide to Clinical Preventive Services","author":"USPSTF","year":"1996"},{"key":"10.1016\/j.ypmed.2007.08.006_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","article-title":"Aspirin for the primary prevention of cardiovascular events: recommendation and rationale","volume":"136","author":"USPSTF","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM200001063420101","article-title":"The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group","volume":"342","author":"van Den Hoogen","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2007.08.006_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.1995.03530020049031","article-title":"Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study","volume":"274","author":"Verschuren","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2007.08.006_bib45","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743507003702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743507003702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:29:20Z","timestamp":1546648160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743507003702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0091743507003702"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2007.08.006","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}